VDO of TEDxDelMar 2011 - Nigel Calcutt, Ph.D. - Preventing and Treating Complications -- What's New?
After we have a tendency to got the information regarding Pathology Assistant Program ago VDO, we will explore the TEDxDelMar 2011 - Nigel Calcutt, Ph.D. - Preventing and Treating Complications -- What's New?. I urge everybody to use judgment in the audience. A recent survey found that I even have stumble upon TEDxDelMar 2011 - Nigel Calcutt, Ph.D. - Preventing and Treating Complications -- What's New?. I saw that it was necessary for them to be revealed. If any errors. I apologize. If you do not wish to publish VDO. i'm pleased to be here. Thanks for a great VDO. TEDxDelMar 2011 - Nigel Calcutt, Ph.D. - Preventing and Treating Complications -- What's New? Tube. Duration : 18.87 Mins.Our theme for TEDxDelMar 2011 was "A Search For A Cure". In this talk, Dr. Calcutt gives us his talk entitled "Preventing and Treating Complications -- What's New?" Dr. Nigel Calcutt received his Bachelor of Science degree in Zoology in 1985 and his Doctor of Philosophy degree in Physiology and Pharmacology in 1988, both from the University of Nottingham. He was then a Postdoc Fellow in Pharmacology at St. Bartholomews Hospital, University of London, UK. Dr. Calcutt was appointed in 1993 as Assistant Adjunct Professor of Pathology at UCSD. He was promoted to Professor in July 2005. Dr. Calcutt's research is focused on mechanisms of peripheral nerve disease and the identification of new therapeutic approaches to prevent onset of neuropathy or alleviate symptoms of an existing neuropathy such as sensory loss or pain. Most students and Fellows in his laboratory work on cellular and animal models of diabetic neuropathy although we also have projects looking at the toxic neuropathies that are side effects of certain cancer drugs and at models of HIV-associated peripheral neuropathy. He has adopted a multi-disciplinary approach to addressing the etiology of diabetic neuropathy and apply a diverse array of techniques that range from molecular and biochemical investigations of fundamental disease mechanisms to physiologic and behavioral assessments of nerve function and the efficacy of potential therapeutic strategies. He also collaborates with a number of biotechnology and ...
We'll get this from me. I am pleased to present the information.
No comments:
Post a Comment